Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis

Background and aims: Progression of chronic cholestatic disorders towards ductopenia results from the dysregulation of cholangiocyte survival, with cell death by apoptosis prevailing over compensatory proliferation. Currently, no therapy is available to sustain cholangiocyte survival in the course of those disorders. It was recently shown that cholangiocytes express the glucagon-like peptide-1 receptor (GLP-1R); its activation results in enhanced proliferative reaction to cholestasis. The GLP-1R selective agonist exendin-4 sustains pancreatic β cell proliferation and prevents cell death by apoptosis. Exendin-4 is now employed in humans as a novel therapy for diabetes. The aim of the present study was to verify whether exendin-4 is effective in preventing cholangiocyte apoptosis. Methods: In vitro, tests were carried out to determine if exendin-4 is able to prevent apoptosis of cholangiocytes isolated from normal rats induced by glycochenodeoxycholic acid (GCDCA); in vivo, animals subjected to 1 week of bile duct ligation and to a single intraperitoneal injection of CCl4 were treated with exendin-4 for 3 days. Results: Exendin-4 prevented GCDCA-induced Bax mitochondrial translocation, cytochrome c release and an increase in caspase 3 activity. Phosphatidylinositol 3-kinase, but not cAMP/protein kinase A or Ca2+/calmodulin-dependent protein kinase inhibitors, neutralised the effects of exendin-4. In vivo, exendin-4 administration prevented the increase in TUNEL (terminal deoxynucleotidyl transferase-mediated triphosphate end-labelling)-positive cholangiocytes and the loss of bile ducts observed in bile duct-ligated rats treated with CCl4. Conclusion: Exendin-4 prevents cholangiocyte apoptosis both in vitro and in vivo; such an effect is due to the ability of exendin-4 to counteract the activation of the mitochondrial pathway of apoptosis. These findings support the hypothesis that exendin-4 may be effective in slowing down the progression of cholangiopathies to ductopenia.

[1]  Y. Chun,et al.  Ceramide induces p38 MAPK-dependent apoptosis and Bax translocation via inhibition of Akt in HL-60 cells. , 2008, Cancer letters.

[2]  S. Glaser,et al.  Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis. , 2007, Gastroenterology.

[3]  S. Glaser,et al.  Cytoprotective effects of taurocholic acid feeding on the biliary tree after adrenergic denervation of the liver , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[4]  S. Glaser,et al.  Thyroid hormone inhibits biliary growth in bile duct-ligated rats by PLC/IP(3)/Ca(2+)-dependent downregulation of SRC/ERK1/2. , 2007, American journal of physiology. Cell physiology.

[5]  B. Bucher,et al.  Glycochenodeoxycholate (GCDC) inhibits cytokine induced iNOS expression in rat hepatocytes. , 2007, The Journal of surgical research.

[6]  M. Haneda,et al.  Chenodeoxycholic acid and taurochenodexycholic acid induce anti‐apoptotic cIAP‐1 expression in human hepatocytes , 2006, Journal of gastroenterology and hepatology.

[7]  W. Yung,et al.  Secretin: A Pleiotrophic Hormone , 2006, Annals of the New York Academy of Sciences.

[8]  G. Svegliati-Baroni,et al.  Estrogens maintain bile duct mass and reduce apoptosis after biliodigestive anastomosis in bile duct ligated rats. , 2006, Journal of hepatology.

[9]  H. Lung,et al.  The increase in mitochondrial association with actin precedes Bax translocation in apoptosis. , 2006, The Biochemical journal.

[10]  S. Glaser,et al.  Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis. , 2006, Gastroenterology.

[11]  S. Glaser,et al.  Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[12]  F. Anania,et al.  Exendin‐4, a glucagon‐like protein‐1 (GLP‐1) receptor agonist, reverses hepatic steatosis in ob/ob mice , 2006, Hepatology.

[13]  U. Beuers,et al.  Phosphatidylinositol 3-kinase-dependent signaling modulates taurochenodeoxycholic acid-induced liver injury and cholestasis in perfused rat livers. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[14]  G. Gores,et al.  Apoptosis: a mechanism of acute and chronic liver injury , 2005, Gut.

[15]  Sibel Özyazgan,et al.  Effect of Glucagon-Like Peptide-1(7–36) and Exendin-4 on the Vascular Reactivity in Streptozotocin/Nicotinamide-Induced Diabetic Rats , 2005, Pharmacology.

[16]  A. Grapin-Botton.  Ductal cells of the pancreas. , 2005, The international journal of biochemistry & cell biology.

[17]  K. Nakanishi,et al.  Translocation of Bim to the Endoplasmic Reticulum (ER) Mediates ER Stress Signaling for Activation of Caspase-12 during ER Stress-induced Apoptosis* , 2004, Journal of Biological Chemistry.

[18]  N. LaRusso,et al.  The cholangiopathies: disorders of biliary epithelia. , 2004, Gastroenterology.

[19]  N. LaRusso,et al.  The Pathophysiology of Biliary Epithelia , 2004 .

[20]  M. Nagaya,et al.  Ductular Cell Proliferation in Islet Cell Neogenesis Induced by Incomplete Ligation of the Pancreatic Duct in Dogs , 2004, Surgery Today.

[21]  D. Drucker,et al.  Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. , 2004, Endocrinology.

[22]  G. Gores,et al.  Apoptosis: The nexus of liver injury and fibrosis , 2004, Hepatology.

[23]  C. Trautwein,et al.  Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. , 2003, Journal of hepatology.

[24]  Dennis D. Kim,et al.  Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes. , 2003, Diabetes care.

[25]  T. Patel,et al.  Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct-ligated rats. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[26]  R. Perfetti,et al.  Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway. , 2003, Endocrinology.

[27]  S. Glaser,et al.  Taurocholate feeding prevents CCl4-induced damage of large cholangiocytes through PI3-kinase-dependent mechanism. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[28]  D. Drucker.  Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. , 2003, Molecular endocrinology.

[29]  G. Gores,et al.  Bile Acids Stimulate cFLIP Phosphorylation Enhancing TRAIL-mediated Apoptosis* , 2003, The Journal of Biological Chemistry.

[30]  F. Lammert,et al.  Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. , 2002, Gastroenterology.

[31]  G. Gores,et al.  Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. , 2002, Gastroenterology.

[32]  C. Webster,et al.  cAMP inhibits bile acid-induced apoptosis by blocking caspase activation and cytochrome c release. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[33]  M. Mattson,et al.  Protection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4 , 2002, Journal of Pharmacology and Experimental Therapeutics.

[34]  B. Petersen,et al.  In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Lewis C Cantley,et al.  The phosphoinositide 3-kinase pathway. , 2002, Science.

[36]  S. Glaser,et al.  Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha , 2002, Hepatology.

[37]  N. LaRusso,et al.  The pathobiology of biliary epithelia , 2002, Hepatology.

[38]  Fuminori Tsuruta,et al.  The Phosphatidylinositol 3-Kinase (PI3K)-Akt Pathway Suppresses Bax Translocation to Mitochondria* , 2002, The Journal of Biological Chemistry.

[39]  D. Drucker.  Biological actions and therapeutic potential of the glucagon-like peptides. , 2002, Gastroenterology.

[40]  C. Steer,et al.  Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation , 1999, Cell Death and Differentiation.

[41]  E. Kandel,et al.  Akt/Protein Kinase B Inhibits Cell Death by Preventing the Release of Cytochrome c from Mitochondria , 1999, Molecular and Cellular Biology.

[42]  S. Glaser,et al.  Acute carbon tetrachloride feeding induces damage of large but not small cholangiocytes from BDL rat liver. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[43]  G. Bringmann,et al.  The Atropisomer-Selective Ring Cleavage of Helically Distorted, Configuratively Unstable Biaryl Lactones with a Chiral Metallated N-Nucleophile - the Complete PM3 Mechanistic Course and its Video Presentation , 1998 .

[44]  C. Steer,et al.  Ursodeoxycholic Acid May Inhibit Deoxycholic Acid-Induced Apoptosis by Modulating Mitochondrial Transmembrane Potential and Reactive Oxygen Species Production , 1998, Molecular medicine.

[45]  S. Glaser,et al.  Regrowth of the rat biliary tree after 70% partial hepatectomy is coupled to increased secretin-induced ductal secretion. , 1996, Gastroenterology.

[46]  G. Gores,et al.  Secretin stimulates exocytosis in isolated bile duct epithelial cells by a cyclic AMP-mediated mechanism. , 1992, The Journal of biological chemistry.

[47]  N. LaRusso,et al.  Isolation and morphologic characterization of bile duct epithelial cells from normal rat liver. , 1989, Gastroenterology.

[48]  L. Sarkozi,et al.  Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules. , 1988, The Journal of clinical investigation.

[49]  M. Kaplan,et al.  Primary Biliary Cirrhosis , 1987, The New England journal of medicine.

[50]  B. Fleshler,et al.  The Liver: Biology and Pathobiology , 1983 .

[51]  S. Glaser,et al.  Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. , 2007, Gastroenterology.

[52]  S. Glaser,et al.  -Dependent Cytoprotective Effects of Ursodeoxycholic and Tauroursodeoxycholic Acid on the Biliary Epithelium in a Rat Model of Cholestasis and Loss of Bile Ducts , 2006 .

[53]  T. Roskams,et al.  Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. , 2005, Gastroenterology.

[54]  Y. Nimura,et al.  Lack of effect of incretin hormones on insulin release from pancreatic islets in the bile duct-ligated rats. , 2001, American journal of physiology. Endocrinology and metabolism.

[55]  K. Lazaridis,et al.  Primary biliary cirrhosis , 1998, Springer Netherlands.